Science and Enterprise

Category: Joint ventures/collaborations

  • Partnership Will Develop Green Training for Pharmacists

    University of the Sciences in Philadelphia, Pennsylvania and Practice Greenhealth (PGH) in Reston, Virgina will collaborate to develop and promote sustainability training for pharmacists, pharmacy students, and related professionals. PGH is a membership organization for institutions in health care that have made a commitment to environmentally-friendly practices. The university and PGH will develop training modules…

  • New Math Tools Developed to Monitor Power Grid

    University and company engineers have developed new mathematical tools for monitoring and measuring electrical power grid performance. The team that developed the tools — from North Carolina State University in Raleigh, Rensselaer Polytechnic Institute in Troy, New York, and Southern California Edison in Los Angeles — published their results in the online issue of IEEE…

  • U.K. University Hosts Environmental Tech Training Center

    The University of Leicester in the U.K. will soon launch a new €3.5 million ($4.54 million) research center to train environmental researchers in using current satellite technologies. The new European Centre of Excellence in Earth Observation Research Training or GIONET is set to begin on 18 January 2011. The center plans to train 14 researchers…

  • Sanofi-Aventis to Support UCSF Research Program

    The French pharmaceutical company Sanofi-aventis said today it will take part in a program at the University of California, San Francisco (UCSF) that encourages innovative biomedical research. Sanofi-aventis will be the first industry partner in UCSF’s Program for Breakthrough Biomedical Research that awards funding to projects of potentially high impact and greater creativity. Sanofi-aventis will…

  • Hershey Grant Funds University Sensory Science Lab

    The Hershey Company in Hershey, Pennsylvania has awarded a grant to Harrisburg (Pennsylvania) University of Science and Technology for a new sensory science and consumer research laboratory. The grant of $90,000 will fund the start-up and operation of the lab for two years. The university says the sensory science and consumer research program is aligned…

  • Eli Lilly, Boehringer Ingelheim to Partner on Diabetes Drugs

    Pharmaceutical manufacturers Eli Lilly and Company in Indianapolis and Boehringer Ingelheim in Germany have agreed to jointly develop and commercialize several of their diabetes compounds in mid- and late-stage development. The total value of the deal could reach $2.37 billion. The agreement covers Boehringer Ingelheim’s two oral diabetes agents — linagliptin and BI10773 — and…

  • National Lab, University Develop Tougher, Stronger Glass

    A group of engineering and materials scientists have developed a new type of damage-tolerant metallic glass, demonstrating a strength and toughness that they say goes beyond that of any known material. The team had members from California Institute of Technology in Pasadena and the U.S. Department of Energy’s Lawrence Berkeley National Laboratory in Berkeley, California.…

  • Consortium to Develop Sanfilippo B Gene Therapy

    Amsterdam Molecular Therapeutics (AMT), a biopharmaceuticalcompany in the Netherlands, and a group of French research institutes, including the Institut Pasteur in Paris, has formed a consortium to develop a gene therapy to treat Sanfilippo B. AMT will manufacture compounds to be tested in a clinical trial of the therapy. Sanfilippo B is a rare genetic…

  • Bristol-Myers Squibb, Biotech Partner on Alzheimer’s Test

    Opko Health Inc., a biotechnology company in Miami, Florida, said today it has a collaboration agreement with the drug manufacturer Bristol-Myers Squibb Company for Opko’s diagnostic test technology. Opko’s blood tests are being developed from its technology that identifies biomarkers for a range of diseases including neurodegenerative disorders. Part of the project calls for Opko…

  • Spirogen, Genentech Partner on Anti-Cancer Therapies

    Spirogen Ltd. a London, U.K. biotechnology company, announced a multi-year research collaboration and license agreement with Genentech, a Roche Group company, to discover and develop antibody drug conjugates (ADCs) as potential anti-cancer agents. The collaboration will make use of Spirogen’s pyrrolobenzodiazepine (PBD) drugs,  a group of natural antibiotics, and associated linking technology. Under the agreement,…